Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 1/20 | 1.00 |
| ▸ | ALOX15 | P16050 | 1/20 | 1.00 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.49 |
| ▸ | GAA | P10253 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2449759 | 1.00 | ALDH1A1 (1.00) | ALDH1A1CYP3A4ALOX15TDP1KDM4E | |
| SCHEMBL17627765 | 1.00 | ALDH1A1 (1.00) | ALDH1A1CYP3A4ALOX15TDP1KDM4E | |
| SCHEMBL31141470 | 1.00 | ALDH1A1 (1.00) | ALDH1A1CYP3A4ALOX15TDP1KDM4E | |
| SCHEMBL9957956 | 1.00 | ALDH1A1 (1.00) | ALDH1A1CYP3A4ALOX15TDP1KDM4E | |
| SCHEMBL115151 | 1.00 | ALDH1A1 (1.00) | ALDH1A1CYP3A4ALOX15TDP1KDM4E | |
| SCHEMBL132162 | 1.00 | ALDH1A1 (1.00) | ALDH1A1CYP3A4ALOX15TDP1KDM4E | |
| SCHEMBL17627764 | 1.00 | ALDH1A1 (1.00) | ALDH1A1CYP3A4ALOX15TDP1KDM4E | |
| SCHEMBL31141469 | 1.00 | ALDH1A1 (1.00) | ALDH1A1CYP3A4ALOX15TDP1KDM4E | |
| SCHEMBL28235614 | 0.95 | ALDH1A1 (0.90) | ALDH1A1CYP3A4ALOX15TDP1KDM4E | |
| SCHEMBL12593725 | 0.91 | ALDH1A1 (0.83) | ALDH1A1CYP3A4ALOX15TDP1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250241356-A1 | ORAL COMPOSITION COMPRISING RECEPTOR MODULATOR | DANIEL MICHAEL S (US) | 2025-07-31 | — | — | US | disclosed |
| EP-4543229-A1 | ORAL COMPOSITION COMPRISING A RECEPTOR MODULATOR | Nicoventures Trading Limited (GB) | 2025-04-30 | — | — | EP | disclosed |
| WO-2023248187-A1 | ORAL COMPOSITION COMPRISING A RECEPTOR MODULATOR | Nicoventures Trading Limited (GB) | 2023-12-28 | — | — | WO | disclosed |
| EP-3541435-A1 | USE OF VOLATILE COMPOSITIONS TO LIMIT OR ELIMINATE PERCEPTION OF FECAL MALODOUR | Firmenich SA (CH) | 2019-09-25 | — | — | EP | disclosed |
| WO-2018091686-A1 | USE OF VOLATILE COMPOSITIONS TO LIMIT OR ELIMINATE PERCEPTION OF FECAL MALODOUR | FIRMENICH SA (CH) | 2018-05-24 | — | — | WO | disclosed |